Aida Soriano
Somerville, NJNPI 1043281124
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 520 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,527 and has fallen 99.4% since, to $16 in 2025.
Across 520 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$1K
- Boehringer Ingelheim$886
- Mylan Specialty L.p.$480
- Grifols USA, LLC$454
- Jazz Pharmaceuticals Inc.$414
- plus $3K from 23 others
What the payments were for
- Food & beverage$7,791100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 100 | $1,500 |
| AstraZeneca | 78 | $1,285 |
| Boehringer Ingelheim | 60 | $886 |
| Mylan Specialty L.p. | 29 | $480 |
| Grifols USA, LLC | 33 | $454 |
| Jazz Pharmaceuticals Inc. | 31 | $414 |
| Sanofi | 16 | $402 |
| Actelion Pharmaceuticals US, Inc. | 20 | $381 |
| Novartis | 24 | $346 |
| Mallinckrodt Hospital Products Inc. | 19 | $243 |
| Regeneron Healthcare Solutions, Inc. | 18 | $236 |
| Genentech USA, Inc. | 18 | $160 |
| E.r. Squibb & Sons, L.L.C. | 10 | $144 |
| Teva Pharmaceuticals USA, Inc. | 11 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $123 |
| Covis Pharma GmbH | 9 | $118 |
| Merck | 6 | $82 |
| Pulmonx Corporation | 3 | $63 |
| Philips North America LLC | 3 | $47 |
| Circassia Inc. | 4 | $46 |
| United Therapeutics Corporation | 4 | $44 |
| Pfizer | 3 | $43 |
| Johnson & Johnson | 3 | $42 |
| Shire North American Group Inc | 3 | $40 |
| Amgen | 2 | $30 |
| Insmed, Inc. | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| CSL Behring | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$233
- TRELEGY ELLIPTA$125
- DUPIXENT$115
- FASENRA$115
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.